SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008209
Filing Date
2024-05-15
Accepted
2024-05-15 07:15:40
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q trvn-20240331x10q.htm   iXBRL 10-Q 1212739
2 EX-31.1 trvn-20240331xex31d1.htm EX-31.1 16917
3 EX-31.2 trvn-20240331xex31d2.htm EX-31.2 16047
4 EX-32.1 trvn-20240331xex32d1.htm EX-32.1 8912
5 EX-32.2 trvn-20240331xex32d2.htm EX-32.2 9256
  Complete submission text file 0001558370-24-008209.txt   6497663

Data Files

Seq Description Document Type Size
6 EX-101.SCH trvn-20240331.xsd EX-101.SCH 53387
7 EX-101.CAL trvn-20240331_cal.xml EX-101.CAL 48869
8 EX-101.DEF trvn-20240331_def.xml EX-101.DEF 198395
9 EX-101.LAB trvn-20240331_lab.xml EX-101.LAB 437775
10 EX-101.PRE trvn-20240331_pre.xml EX-101.PRE 332601
72 EXTRACTED XBRL INSTANCE DOCUMENT trvn-20240331x10q_htm.xml XML 1140660
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36193 | Film No.: 24947131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)